Skip to main content
Log in

Tacalcitol (1,24(OH)2D3, TV-02) inhibits phorbol ester-induced epidermal proliferation and cutaneous inflammation, and induces epidermal differentiation in mice

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

In this study, we examined the cutaneous effects of tacalcitol [1, 24(R)(OH)2D3] on epidermal proliferation, differentiation, and skin inflammation in vivo using hairless mice. Tacalcitol was shown to inhibit epidermal proliferation using TPA-induced ornithine decarboxylase activity and DNA synthesis as indices, and the induction of epidermal differentiation using type I transglutaminase activity as an index. Tacalcitol also displayed an antiinflammatory effect on TPA-induced inflammatory changes histopathologically. These results confirm the clinical efficacy of tacalcitol in psoriasis, and suggest that it may be efficacious in the treatment of other inflammatory skin diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Astrup EG, Iversen OH (1981) Cell population kinetics in hairless mouse epidermis following a single topical application of 12-O-tetradecanoylphorbol-13-acetate., Carcinogenesis 2 (10):999–1006

    PubMed  CAS  Google Scholar 

  2. Burton K (1956) A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid, Biochem J 62:315–323

    PubMed  CAS  Google Scholar 

  3. Burton K (1968) Determination of DNA concentration with diphenylamine. Methods Enzymol 12:163–166

    Article  CAS  Google Scholar 

  4. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y (1982) Direct activation of calcium activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257:7847–7851

    PubMed  CAS  Google Scholar 

  5. Chida K, Hashiba H, Suda T, Kuroki T (1984) Inhibition by 1α,25-dihydroxyvitamin D3 of induction of epidermal ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate and teleocidin B. Cancer Res 44:1387–1391

    PubMed  CAS  Google Scholar 

  6. Clemens TL, Garrett PK, Zhou XY, Pike JW, Haussler RM, Dempster WD (1988) Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. Endocrinology 122:1224–1230

    PubMed  CAS  Google Scholar 

  7. Connerty HV, Briggs AR (1966) Determination of serum calcium by means of orthocresolphthalein complexone. Am J Clin Pathol 45(3):290–296

    PubMed  CAS  Google Scholar 

  8. Connor MJ, Lowe NJ (1983) Induction of ornithine decarboxylase activity and DNA synthesis in hairless mouse epidermis by retinoids. Cancer Res 43:5174–5177

    PubMed  CAS  Google Scholar 

  9. Cooper KD, Baadsgaard O, Elder JT, Sauder DN, Voorhees JJ, Fisher GJ (1988) Increased levels of an interleukin-1 inhibitor block interleukin-1 activity but not immunoreactivity or mRNA expression of interleukin-1 beta in psoriasis skin. J Invest Dermatol 90:552

    Google Scholar 

  10. Esmann J, Cooper KD, Voorhees JJ, Fisher GJ (1988) Membrane associated transglutaminase activity is increased in psoriatic involved versus normal epidermis. J Invest Dermatol 90:556

    Google Scholar 

  11. George MD, Vollberg TM, Floyd EE, Stein JP, Jetten AM (1990) Regulation of transglutaminase type II by transforming growth factor-β1 in normal and transformed human epidermal keratinocyte. J Biol Chem 265(19):11098–11104

    PubMed  CAS  Google Scholar 

  12. Gerritsen MJP, Boezeman JBM, Van Vlijmen-Willems IMJJ, Van De Kerkhof PCM (1994) The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br J Dermatol 131:57–63

    Article  PubMed  CAS  Google Scholar 

  13. Gupta AK, Fisher GJ, Elder JT, Nickoloff BJ, Voorhees JJ (1988) Spningosine inhibits phorbol ester-induced inflammation, ornithine decarboxylase activity and activation of protein kinase C in mouse skin. J Invest Dermatol 91:486–491

    Article  PubMed  CAS  Google Scholar 

  14. Gupta AK, Fisher GJ, Elder JT, Talwar HS, Esmann J, Duell EA, Nickoloff BJ, Voorhees JJ (1989) Topical cyclosporine A inhibits the phorbol ester induced hyperplastic inflammatory response but not protein kinase C activation in mouse epidermis. J Invest Dermatol 93:379–386

    Article  PubMed  CAS  Google Scholar 

  15. Hammarstrom S, Lindgren JA, Marcel C, Duell EA, Anderson TF, Voorhees JJ (1975) Increased concentration of non-esterified arachidonic acid. 12L-hydroxy-5,8,10,14-eicostetraenoic acid, prostaglandin E2 and prostaglandin F2a in the epidermis of psoriasis. Proc Natl Acad Sci USA 72:5130–5134

    Article  PubMed  CAS  Google Scholar 

  16. Holick M, Smith E, Pincus S (1987) Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Arch Dermatol 123:1677a-1683a

    Article  Google Scholar 

  17. Horn F, Marks F, Fisher GJ, Marcelo CLK, Voorhees JJ (1987) Decreased protein kinase C activity in psoriatic versus normal epidermis. J Invest Dermatol 88:220–222

    Article  PubMed  CAS  Google Scholar 

  18. Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T (1983) Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3. Endocrinology 113:1950–1957

    Article  PubMed  CAS  Google Scholar 

  19. Inoue H, Tanioka H, Shiba K, Asada A, Kato Y, Takeda Y (1974) Effect of isoproterenol on polyamine metabolism in mouse salivary glands. J Biochem 75:679–687

    PubMed  CAS  Google Scholar 

  20. Ishida H, Norman AW (1988) Demonstration of high affinity receptor for 1,25(OH)2D3 in rat pancreas. Mol Cell Endocrinol 60:109–117

    Article  PubMed  CAS  Google Scholar 

  21. Janne J, Raina A, Siimes M (1968) Stimulation of polyamine synthesis by growth hormone in rat liver. Biochim Biophys Acta 166:419–426

    PubMed  CAS  Google Scholar 

  22. Kato T, Tadaki T, Terui T, Tagami H (1989) Treatment of psoriasis by synthetic bioactive vitamin D3, 1α,24-hydroxycholecalciferol ointment. Acta Dermatol 84:43–436

    Google Scholar 

  23. Kay JE, Lindsay VJ (1973) Polyamine synthesis during lymphocyte activation. Exp Cell Res 77:428–436

    Article  PubMed  CAS  Google Scholar 

  24. Kobayashi T, Okuma H, Azuma Y, Kiyoki M, Matsumoto K, Hashimoto K, Yoshikawa K (1990) 1α,24R-Dihydroxyvitamin D3 has an ability comparable to that of 1α,25-dihydroxyvitamin D3 to induce keratinocyte differentiation. J Dermatol 17:707–709

    PubMed  CAS  Google Scholar 

  25. Kragballe K (1992) Vitamin D analogues in the treatment of psoriasis. J Cell Biochem 49:46–52

    Article  PubMed  CAS  Google Scholar 

  26. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K (1989) The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243 (4897):1464–1466

    Article  PubMed  CAS  Google Scholar 

  27. Larsen CG, Kristensen M, Pauldan K, Deleuran B, Thomas MK, Zachariae C, Kragballe K, Matsushima K, Thestrup-Pedersen K (1991) 1,25(OH)2D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. Biochem Biophys Res Commun 176(3):1020–1026

    Article  PubMed  CAS  Google Scholar 

  28. Marks F, Bertsch S, Furstenberger G (1979) Ornithine decarboxylase activity, cell proliferation, and tumor promotion in mouse epidermis in vivo. Cancer Res 39:4183–4188

    PubMed  CAS  Google Scholar 

  29. Marks F, Fürstenberger G, Kownatzki E (1981) Prostaglandin E-mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore A23187 and by tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 41:696–702

    PubMed  CAS  Google Scholar 

  30. Matsumoto K, Hashimoto K, Kiyoki M, Yamamoto M, Yoshikawa K (1990) Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes. J Dermatol 17:97–103

    PubMed  CAS  Google Scholar 

  31. Matsunaga T, Yamamoto M, Mimura H, Ohta T, Kiyoki M, Ohba T, Naruchi T, Hosoi J, Kuroki T (1990) 1,24(R)-Dihydroxyvitamin D3, a novel active form of vitamin D3 with high activity for inducing epidermal differentiation but decreased hypercalcemic activity. J Dermatol 17:135–142

    PubMed  CAS  Google Scholar 

  32. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W (1988) Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 167(6):1883–1893

    Article  PubMed  CAS  Google Scholar 

  33. Morimoto S, Kumahara Y (1985) A patient with psoriasis cured by 1α-hydroxyvitamin D3. Med J Osaka Univ 35:51

    PubMed  CAS  Google Scholar 

  34. Murdoch D, Clissold SP (1992) Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Drugs 43(3):415–429

    Article  PubMed  CAS  Google Scholar 

  35. Nair S, Mayotte J, Lokshin A, Levitt M (1994) Induction of squamous differentiation by interferon β in a human non-small-cell lung cancer cell line. J Natl Cancer Inst 86(5):378–383

    PubMed  CAS  Google Scholar 

  36. Nishimura M, Hori Y, Nishiyama S, Nakamizo Y (1993) Topical 1α,24(R)-dihydroxyvitamin D3 for the treatment of psoriasis. Review of the literature. Eur J Dermatol 3:255–261

    CAS  Google Scholar 

  37. O’Brien TG (1976) The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res 36:2644–2653

    PubMed  CAS  Google Scholar 

  38. O’Brien TG, Simsiman RC, Boutwell RK (1975) Induction of polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res 35:1662–1670

    PubMed  CAS  Google Scholar 

  39. Ohta T, Takada Y, Mimura H, Yamamoto M, Matsunaga T, Kiyoki M, Ohba T, Naruchi T (1990) Pharmacokinetic studies of 1α,24(R)-(OH)2D3 (TV-02) (1): Plasma level, distribution metabolism and excretion after a single subcutaneous administraton to rats. Yakubutsu Doutai 5:3–24

    CAS  Google Scholar 

  40. Ohta T, Yamamoto M, Takada Y, Mimura H, Matsunaga T, Kiyoki M, Ohba T, Naruchi T (1990) Pharmacokinetic studies of 1α,24(R)-(OH)2D3 (TV-02) (3): Absorption, distribution and excretion after a single or continuous transcutaneous application to rats. Yakubutsu Doutai 5:39–52

    CAS  Google Scholar 

  41. Raick AN (1973) Ultrastructural histological and biochemical alterations produced by 12-O-tetradecanoylphorbol-13-acetate on mouse epidermis and their relevance to skin tumor promotion. Cancer Res 33:269–286

    PubMed  CAS  Google Scholar 

  42. Russell DH, Levy CC (1973) The roles of the polyamines, putrescine, spermidine, and spermine in normal and malignant tissues. Life Sci 13:1635–1647

    Article  PubMed  CAS  Google Scholar 

  43. Russell DH, McVicker TA (1971) Polyamine metabolism in mouse liver after partial hepatectomy. Biochim Biophys Acta 244:85–93

    PubMed  CAS  Google Scholar 

  44. Russell DH, Snyder SH (1968) Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc Natl Acad Sci USA 68:1420–1426

    Article  Google Scholar 

  45. Russell DH, Combest WL, Duell EA, Stawiski M, Anderson TF, Voorhees JJ (1978) Glucocorticoid inhibits elevated polyamine biosynthesis in psoriasis. J Invest Dermatol 71:177–181

    Article  PubMed  CAS  Google Scholar 

  46. Smith EL, Walworth NC, Holick MF (1986) Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 86:709–714

    Article  PubMed  CAS  Google Scholar 

  47. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, Suda T (1982) 1α,25-Dihydroxycholecalciferol and a human myeloid leukemia cell line (HL-60): The presence of a cytosol receptor and induction of differentiation. Biochem J 204:713–719

    PubMed  CAS  Google Scholar 

  48. Voorhees JJ (1983) Leukotrienes and other lipoxygenase products in pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol 119:541–547

    Article  PubMed  CAS  Google Scholar 

  49. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ (1987) Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84(24):9233–9237

    Article  PubMed  CAS  Google Scholar 

  50. Yuspa SH, Ben T, Hennings H, Lichti U (1980) Phorbol ester tumor promoters induce epidermal transglutaminase activity. Biochem Biophys Res Commun 97:700–708

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sato, H., Sugimoto, I., Matsunaga, T. et al. Tacalcitol (1,24(OH)2D3, TV-02) inhibits phorbol ester-induced epidermal proliferation and cutaneous inflammation, and induces epidermal differentiation in mice. Arch Dermatol Res 288, 656–663 (1996). https://doi.org/10.1007/BF02505274

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02505274

Key words

Navigation